Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Euro-Med Laboratories Philippines's
Operating Income
for the
three
months ended in Mar. 2026 was ₱181 Mil. Euro-Med Laboratories Philippines's Interest Expense for the
three
months ended in Mar. 2026 was ₱-74 Mil.
Euro-Med Laboratories Philippines's interest coverage for the quarter that ended in Mar. 2026 was 2.46.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Euro-Med Laboratories Philippines's Interest Coverage or its related term are showing as below:
PHS:EURO'
s Interest Coverage Range Over the Past 10 Years
Min: 1.91 Med: 2.72 Max: 4.2
Current: 2.97
PHS:EURO's Interest Coverage is ranked worse than 78.95% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs PHS:EURO: 2.97
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Euro-Med Laboratories Philippines Interest Coverage Related Terms
Euro-Med Laboratories Philippines Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
PHS:EURO vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines (PHS:EURO) has a Interest Coverage of 2.46 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 10% below median its historical median of 2.72. Over the past decade, Euro-Med Laboratories Philippines' Interest Coverage has ranged from 1.91 to 4.20. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #540 out of 684 companies in the Drug Manufacturers industry, placing it in the top 78.9%.
Is Euro-Med Laboratories Philippines' Interest Coverage too high?
Euro-Med Laboratories Philippines' current Interest Coverage of 2.46 is 10% below median its 10-year median of 2.72. Over the past 10 years, this metric has ranged from a low of 1.91 to a high of 4.20. The Drug Manufacturers industry median Interest Coverage is 12.77. Euro-Med Laboratories Philippines' value of 2.46 is 80.7% below this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #540 out of 684 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #540 out of 684 companies for Interest Coverage. This places Euro-Med Laboratories Philippines in the lower half of its industry. The industry median Interest Coverage is 12.77. Euro-Med Laboratories Philippines' value of 2.46 is 80.7% below this benchmark. Historically, Euro-Med Laboratories Philippines' own Interest Coverage has ranged from 1.91 to 4.20 over the past decade. While the company's 10-year median is 2.72 vs. the industry median of 12.77, Euro-Med Laboratories Philippines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current Interest Coverage of 2.46 is 80.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current Interest Coverage is 2.46, which is 10% below median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.07 — trading 4.9% above its estimated fair value. The current Interest Coverage is 2.46, which is 10% below median its 10-year median of 2.72 and 80.7% below the Drug Manufacturers industry median of 12.77. Euro-Med Laboratories Philippines' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Interest Coverage is 2.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.07 is trading 4.9% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
Interest Coverage: 2.46 (10% below median its 10-year median of 2.72)
GF Value™: ₱1.02 vs. price of ₱1.07 (4.9% above fair value)
Industry Position: 80.7% below the Drug Manufacturers median (#540 of 684)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
82GF Score
Get the complete analysis for PHS:EURO
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
